FDA approves 3 new dosage strengths for Vyvanse

Vyvanse (lisdexamfetamine dimesylate) will now be offered in 20mg, 40mg and 60mg strengths in addition to 30mg, 50mg and 70mgs. Vyvanse is a stimulant that is FDA-approved for the treatment of ADHD. The new dosages should be available sometime before the end of March 2008.

http://money.cnn.com/news/newsfeeds/articles/newstex/AFX-0013-22012011.htm

By Stephanie Sarkis|2016-10-05T06:46:15-04:00January 3rd, 2008|Categories: ADHD, Medication|Tags: FDA, Vyvanse|Comments Off

About the Author: Stephanie Sarkis

Dr. Stephanie Sarkis is a National Certified Counselor (NCC), Licensed Mental Health Counselor (LMHC), and AMHCA Diplomate and Clinical Specialist in Child and Adolescent Counseling based in Tampa Bay, Florida, where she specializes in the treatment of ADD/ADHD. Dr. Sarkis conducts evaluations, testing, diagnosis, and counseling services. She also is a public speaker, consultant, coach, and is a facilitator in collaborative law.